Hello,
I am new to this forum. It seems like an amazing support community.
My dad is 72, PSA is rising after radiation treatment and hormone therapy for the past 2 years. He has now become castrate resistant and mets on bones in his pelvic area, arm, spine and neck.
He has the following options.
1) Abiraterone with denosumab and prednisone
2) Join a clinical trial which combines the above along with immunotheraphy (pembrolizumab). I've read some papers, and while some have experienced very positive benefits, these seems overall, there is not much benefit.
3) Last option is to see if his cancer is genetic. If so, he will qualify for a trial that combines option 1 with a PARP inhibitor (Niraparib). However, we have to wait a couple of weeks for the results of this test to see if he qualifies. Also, half the patients will receive a placebo.
I just wanted to hear some feedback if anyone has used PARP inhibitors and if its worth the wait.